Share prices in biotechnology floundered in 2006, but the analysts say that Big Biotech should be a top performer in 2007. The theory: In a softening economy, profitable biotech companies look like a good defensive maneuver, driving share prices higher. Among the most highly touted stocks: Genentech [1]; Amgen [2]; Celgene and Gilead Sciences [3]. It will be interesting to see how good the analysts are at picking biotech stocks, a notoriously tricky [4] sector for investors.
- read the report [5] on biotech stocks from CNNMoney
Related Articles:
The 10 Commandments of biotech investing. Part 1 [6] | Part 2 [7]
The best (and worst) biotech stocks of 2006. Report [8]
Links:
[1] http://www.fiercebiotech.com/story/genentech-hiring-researchers-in-big-rd-push/2007-01-10
[2] http://www.fiercebiotech.com/story/major-challenges-loom-for-amgen/2006-10-26
[3] http://www.fiercebiotech.com/story/gilead-shares-surge-on-2-5b-myogen-buyout/2006-10-02
[4] http://www.fiercebiotech.com/story/the-biotech-haunted-house/2006-11-03
[5] http://money.cnn.com/2007/01/10/news/companies/biotech/index.htm
[6] http://www.fiercebiotech.com/story/the-10-commandments-of-biotech-investing/2006-10-19
[7] http://www.fiercebiotech.com/story/the-10-commandments-for-biotech-investing-part-two/2006-10-20
[8] http://www.fiercebiotech.com/node/4761